0001553878-18-000027.txt : 20180316 0001553878-18-000027.hdr.sgml : 20180316 20180316170555 ACCESSION NUMBER: 0001553878-18-000027 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20180314 FILED AS OF DATE: 20180316 DATE AS OF CHANGE: 20180316 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Vaishnaw Akshay CENTRAL INDEX KEY: 0001458494 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36407 FILM NUMBER: 18696518 MAIL ADDRESS: STREET 1: 300 THIRD STREET CITY: CAMBRIDGE STATE: MA ZIP: 02139 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ALNYLAM PHARMACEUTICALS, INC. CENTRAL INDEX KEY: 0001178670 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 770602661 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 300 THIRD STREET CITY: CAMBRIDGE STATE: MA ZIP: 02142 BUSINESS PHONE: (617) 551-8200 MAIL ADDRESS: STREET 1: 300 THIRD STREET CITY: CAMBRIDGE STATE: MA ZIP: 02142 FORMER COMPANY: FORMER CONFORMED NAME: ALNYLAM PHARMACEUTICALS INC DATE OF NAME CHANGE: 20020724 4 1 edgardoc.xml PRIMARY DOCUMENT X0306 4 2018-03-14 0 0001178670 ALNYLAM PHARMACEUTICALS, INC. ALNY 0001458494 Vaishnaw Akshay 300 THIRD STREET CAMBRIDGE MA 02142 0 1 0 0 President, R&D Common Stock 2018-03-14 4 M 0 44641 18.66 A 55856 D Common Stock 2018-03-14 4 M 0 38913 16.43 A 94769 D Common Stock 2018-03-14 4 M 0 5000 7.1 A 99769 D Common Stock 2018-03-14 4 S 0 6453 140.45 D 93316 D Common Stock 2018-03-14 4 S 0 15000 141.69 D 78316 D Common Stock 2018-03-14 4 S 0 21336 142.57 D 56980 D Common Stock 2018-03-14 4 S 0 19213 143.46 D 37767 D Common Stock 2018-03-14 4 S 0 20172 144.53 D 17595 D Common Stock 2018-03-14 4 S 0 6380 145.27 D 11215 D Common Stock 338 I by Managed Account Stock Option (right to buy) 7.1 2018-03-14 4 M 0 5000 0.0 D 2021-11-30 Common Stock 5000 0 D Stock Option (right to buy) 16.43 2018-03-14 4 M 0 38913 0.0 D 2019-12-09 Common Stock 38913 0 D Stock Option (right to buy) 18.66 2018-03-14 4 M 0 44641 0.0 D 2022-12-20 Common Stock 44641 0 D All sales reported on this Form 4 were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on January 10, 2018. Sale prices ranged from $140.00 to $140.95 Sale prices ranged from $141.01 to $142.00 Sale prices ranged from $142.01 to $143.00 Sale prices ranged from $143.01 to $143.98 Sale prices ranged from $144.01 to $145.00 Sale prices ranged from $145.01 to $145.80 The reporting person owns 338 shares of ALNY common stock under the ALNY 401(k) plan as a result of the ALNY 401(k) matching contribution program. The stock option vests as to 25% of the shares on the 1st anniversary of the date of the stock option grant and as to an additional 6.25% of the shares each successive three month period thereafter. By: /s/ Michael P. Mason, Attorney-in-Fact For: Akshay K. Vaishnaw 2018-03-16